Price (90d)
No price history yet — the daily price refresh runs once a day.
Signal Score (90d)
90Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $8.97M | $-5.72M | $-0.07 |
| 2024 | $8.63M | $-4.71M | $-0.06 |
| 2023 | $9.83M | $-6.93M | $-0.10 |
| 2022 | $8.81M | $-8.71M | $-0.12 |
| 2021 | $10.30M | $-6.82M | $-0.10 |
Social Signal Score
Earnings
Thu, Nov 12(in 3 months)
Consensus estimate $-0.01 per share
Typical surprise -33.3% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Aug 13$-0.01 vs $-0.01beat
- Wed, May 13$-0.01 vs $-0.01beat
- Tue, Mar 31$-0.02 vs $-0.01miss
- Thu, Nov 13$-0.01 vs $-0.01beat
- Thu, Aug 14$-0.02 vs $-0.01miss
- Tue, Apr 15$-0.03 vs $-0.01miss
Estimates and results for MLSS via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
MLSShas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Mentions (2)
- Newsseekingalpha.com·1d ago·Positive
Milestone Scientific Inc. (MLSS) Q2 2026 Earnings Call Transcript Milestone Scientific Inc. (MLSS) Q2 2026 Earnings Call Transcript
View source ↗ - Newsglobenewswire.com·1d ago·Negative
…utlook for Double-Digit Revenue Growth, Including Significant Growth in CompuFlo® Sales ROSELAND, N.J., Aug. 14, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the three and six months ended June 30, 2026.
View source ↗
